Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medinutra is an Italian biotechnology company and a spin-off from the University of Siena that specializes in the research and development of natural bioactive compounds. The company focuses on the extraction and purification of polyphenols, particularly hydroxytyrosol derived from olive oil production byproducts, to create high-efficacy nutraceuticals. Medinutra's products are designed to address metabolic and cardiovascular health by leveraging the antioxidant and anti-inflammatory properties of Mediterranean plant extracts. Their business model combines academic research with industrial application, providing evidence-based ingredients for the functional food and pharmaceutical industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medinutra.